MiniMed Group, Inc.

MMED Healthcare Medical Instruments & Supplies

MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.

18.23 1.06 −5.50%
Market cap
$5.1B
P/E
0.0×
Fwd P/E
27.8×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−3.09
Dividend safety
n/a

MiniMed Group, Inc. (MMED) Debt to equity

Alert me on Debt to equity

MiniMed Group, Inc.'s debt to equity at the end of the quarter to 31 July 2026 was 0.0×, down 0.0× from fiscal 2026 (0.0×). That is below the Medical Instruments & Supplies industry median of 0.1× and in line with the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2026 0.0× —
FY2025 0.0× —
FY2024 0.0× —

Quarterly newest first

Period Debt to equity Change
Jul 2026 0.0× —
Apr 2026 0.0× —
Jan 2026 0.0× —
Jul 2025 0.0× —
2 more quarters

Debt to equity against peers

Company Debt to equity
PLSE Pulse Biosciences, Inc compare 0.0×
MMED MiniMed Group, Inc. 0.0×
ATRC AtriCure, Inc. compare 0.1×
STVN Stevanato Group S.p.A. compare 0.3×
MMSI Merit Medical Systems, Inc. compare 0.4×
NVST Envista Holdings Corporation compare 0.5×
ICUI ICU Medical, Inc. compare 0.5×
BLCO Bausch + Lomb Corporation compare 0.8×
TFX Teleflex Incorporated compare 1.0×
Medical Instruments & Supplies industry median 0.1×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on MMED